Imaging could help tailor treatment of liver tumors

10/24/2013 | MolecularImaging.net

Imaging with SPECT or MR may help evaluate and possibly predict outcomes from radioembolization with Ho-166 microspheres, a team of researchers found. Results of a quantitative analysis of 15 patients who underwent radioembolization published in the Journal of Nuclear Medicine, showed that "using Ho-166 microspheres, in vivo dosimetry based on SPECT and MR imaging correlated well for dose to liver segments and dose to tumors," the authors wrote. In terms of treatment prediction, "Suboptimal treatment can be detected by MR imaging and SPECT, and a pretreatment plan can be elaborated to ensure the full efficacy of the treatment."

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID